This brand name is authorized in Nigeria.
The drug PILFERON contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
R5L488RY0Q - FERROUS FUMARATE
|
|
Ferrous fumarate is an easily absorbed source of iron for replacement therapy. It is a salt of ferrous iron with an organic acid and is less irritant to the gastro-intestinal tract than salts with inorganic acids. Iron and iron salts should be given for the treatment or prophylaxis of iron deficiency anaemias. |
|
2
|
UNII
935E97BOY8 - FOLIC ACID
|
|
Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A11-100791 | Tablet | Pilferon+++ (check strength format) TAB 210mg; 0.6mg 10 x 10 (in Alu-PVC blisters) | Deep red, circular, biconvex sugar coated tablet plain on both sides 11 NF-PP-343972 Pilferon Tablet Ferrous Fumarate & Folic Acid Tablet Each sugar coated tablet contains: Ferrous Fumarate 210mg equivalent to elemental iron (approximately) 68.25mg; Folic Acid 0.6mg. A11-100791 Drugs VARIOUS Nigerian Products 1010 OTC 7/19/2023 PHAMATEX INDUSTRIES LIMITED, , CRYSTAL GLASS CLOSE, BEHIND ABC TRANSPORT, AMUWO ODOFIN IDUSTRIAL ESTATE, LAGOS MAINLAND LAGOS 18444907 finnax2019@gmail.com PHAMATEX INDUSTRIES LTD, 1, CRYSTAL GLASS CLOSE, AMUWO ODOFIN INDUSTRIAL ESTATE, LAGOS NIGERIA, Nigeria | 22/11/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B03AD02 | Ferrous fumarate and folic acid | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AD Iron in combination with folic acid |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A11-100791 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.